West High Yield Resources (WHY.V) announces milestone for Magnesium Project
Top 5 Gainers and Losers: GXU.V, SANU.CN, BTR.V
Are stock markets about to crash hard?
Revive Therapeutics (RVV.CN) announces FDA acceptance of meeting request
Top 5 Gainers and Losers: LAC.TO, WEED.TO, OML.V
BC Bud Corp (BCBC.C) breathes new life into the cannabis space, up 3x in two months
Vancouver media personality, Jody Vance, took time to talk with Medexus Pharmaceuticals (MDP.V) CEO and director Ken d’Entremonet to get a better look at the company’s specialty pharma portfolio and what investors can look forward to over 2021. Tune in!
Full disclosure: Medexus Pharmaceuticals is an Equity.Guru marketing client
